Parallel Advisors, LLC Eli Lilly & CO Transaction History

Parallel Advisors, LLC

$4.18 Billion
Q3 2024

A detailed history of Parallel Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Parallel Advisors, LLC holds 23,649 shares of LLY stock, worth $18.8 Million. This represents 0.5% of its overall portfolio holdings.

Number of Shares

23,649

Previous 24,273 2.57%

Holding current value

$18.8 Million

Previous $22 Million 4.66%

% of portfolio

0.5%

Previous 0.57%

34 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$772.14 - $960.02 $481,815 - $599,052	-624 Reduced 2.57%	23,649 $21 Million
Q2 2024 Aug 08, 2024	BUY	$724.87 - $909.04 $382,006 - $479,064	527 Added 2.22%	24,273 $22 Million
Q1 2024 May 06, 2024	BUY	$592.2 - $792.28 $343,476 - $459,522	580 Added 2.5%	23,746 $18.5 Million
Q4 2023 Feb 09, 2024	BUY	$525.19 - $619.13 $55,670 - $65,627	106 Added 0.46%	23,166 $13.5 Million
Q3 2023 May 20, 2024	BUY	$434.7 - $599.3 $144,755 - $199,566	333 Added 1.47%	23,060 $12.4 Million
Q3 2023 Nov 13, 2023	BUY	$434.7 - $599.3 $144,755 - $199,566	333 Added 1.47%	23,060 $12.4 Million
Q2 2023 May 20, 2024	BUY	$350.74 - $468.98 $250,428 - $334,851	714 Added 3.24%	22,727 $10.7 Million
Q2 2023 Aug 04, 2023	BUY	$350.74 - $468.98 $250,428 - $334,851	714 Added 3.24%	22,727 $10.7 Million
Q1 2023 May 20, 2024	SELL	$310.63 - $364.82 $538,321 - $632,233	-1,733 Reduced 7.3%	22,013 $7.56 Million
Q1 2023 Apr 25, 2023	BUY	$310.63 - $364.82 $510,675 - $599,764	1,644 Added 8.07%	22,013 $7.56 Million
Q4 2022 Feb 03, 2023	BUY	$321.55 - $374.67 $179,746 - $209,440	559 Added 2.82%	20,369 $7.45 Million
Q3 2022 Nov 10, 2022	BUY	$296.48 - $337.87 $126,300 - $143,932	426 Added 2.2%	19,810 $6.41 Million
Q2 2022 Aug 01, 2022	BUY	$278.73 - $327.27 $57,418 - $67,417	206 Added 1.07%	19,384 $6.29 Million
Q1 2022 Apr 28, 2022	BUY	$234.69 - $291.66 $834,557 - $1.04 Million	3,556 Added 22.76%	19,178 $5.56 Million
Q4 2021 Jan 20, 2022	BUY	$224.85 - $279.04 $146,827 - $182,213	653 Added 4.36%	15,622 $4.32 Million
Q3 2021 Nov 02, 2021	SELL	$221.6 - $272.71 $427,688 - $526,330	-1,930 Reduced 11.42%	14,969 $3.46 Million
Q2 2021 Aug 06, 2021	BUY	$180.55 - $233.54 $97,316 - $125,878	539 Added 3.29%	16,899 $3.88 Million
Q1 2021 Apr 23, 2021	BUY	$164.32 - $212.72 $502,161 - $650,072	3,056 Added 22.97%	16,360 $3.06 Million
Q4 2020 Feb 02, 2021	SELL	$130.46 - $172.63 $287,272 - $380,131	-2,202 Reduced 14.2%	13,304 $2.25 Million
Q3 2020 Oct 27, 2020	BUY	$146.22 - $169.13 $15,937 - $18,435	109 Added 0.71%	15,506 $2.3 Million
Q2 2020 Jul 16, 2020	SELL	$136.42 - $164.18 $328,772 - $395,673	-2,410 Reduced 13.53%	15,397 $2.53 Million
Q1 2020 Apr 27, 2020	SELL	$119.05 - $147.35 $470,128 - $581,885	-3,949 Reduced 18.15%	17,807 $2.47 Million
Q4 2019 Jan 30, 2020	BUY	$106.92 - $132.43 $168,505 - $208,709	1,576 Added 7.81%	21,756 $2.86 Million
Q3 2019 Nov 01, 2019	SELL	$106.79 - $116.16 $61,297 - $66,675	-574 Reduced 2.77%	20,180 $2.26 Million
Q2 2019 Aug 05, 2019	SELL	$110.79 - $129.32 $160,091 - $186,867	-1,445 Reduced 6.51%	20,754 $2.3 Million
Q1 2019 May 01, 2019	SELL	$111.31 - $131.02 $173,977 - $204,784	-1,563 Reduced 6.58%	22,199 $2.88 Million
Q4 2018 Feb 05, 2019	SELL	$105.9 - $118.64 $26,263 - $29,422	-248 Reduced 1.03%	23,762 $2.75 Million
Q3 2018 Nov 01, 2018	BUY	$85.86 - $107.31 $290,550 - $363,137	3,384 Added 16.41%	24,010 $2.58 Million
Q2 2018 Jul 30, 2018	SELL	$75.7 - $86.88 $2,422 - $2,780	-32 Reduced 0.15%	20,626 $1.76 Million
Q1 2018 May 08, 2018	BUY	$74.21 - $87.6 $6,307 - $7,445	85 Added 0.41%	20,658 $1.6 Million
Q4 2017 Feb 13, 2018	SELL	$81.94 - $87.89 $3,113 - $3,339	-38 Reduced 0.18%	20,573 $1.74 Million
Q3 2017 Nov 15, 2017	BUY	$77.07 - $85.54 $1.59 Million - $1.76 Million	20,611 New	20,611 $1.71 Million
Q3 2017 Nov 14, 2017	SELL	$77.07 - $85.54 $1.61 Million - $1.79 Million	-20,888 Closed	0 $0
Q2 2017 Aug 07, 2017	BUY	N/A	20,888	20,888 $1.73 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.

Account

Parallel Advisors, LLC Eli Lilly & CO Transaction History